|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
|
CA2524569C
(en)
|
2002-05-03 |
2013-10-22 |
Duke University |
A method of regulating gene expression
|
|
US8106180B2
(en)
*
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
WO2005017145A1
(ja)
|
2003-08-13 |
2005-02-24 |
Japan Biological Informatics Consortium |
機能性rnaが制御する被制御遺伝子の同定・予測方法及びその利用方法
|
|
US7795419B2
(en)
*
|
2004-05-26 |
2010-09-14 |
Rosetta Genomics Ltd. |
Viral and viral associated miRNAs and uses thereof
|
|
US20070099196A1
(en)
|
2004-12-29 |
2007-05-03 |
Sakari Kauppinen |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
US20090209621A1
(en)
|
2005-06-03 |
2009-08-20 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
|
ITMI20051248A1
(it)
|
2005-07-01 |
2007-01-02 |
Vimar Spa |
Modem per bus per impianti elettrici civili ed industriali
|
|
US8481505B2
(en)
|
2005-09-12 |
2013-07-09 |
The Ohio State University Research Foundation |
Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
|
|
US8603991B2
(en)
|
2005-11-18 |
2013-12-10 |
Gradalis, Inc. |
Individualized cancer therapy
|
|
CA2634046A1
(en)
|
2005-12-12 |
2007-06-21 |
The University Of North Carolina At Chapel Hill |
Micrornas that regulate muscle cell proliferation and differentiation
|
|
EP2484782B1
(en)
|
2006-01-05 |
2015-11-18 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
WO2007143752A2
(en)
|
2006-06-09 |
2007-12-13 |
The Regents Of The University Of California |
Targets in breast cancer for prognosis or therapy
|
|
US20100292299A1
(en)
|
2006-06-20 |
2010-11-18 |
Mendell Joshua T |
Nucleotide Motifs Providing Localization Elements and Methods of Use
|
|
US8114982B2
(en)
|
2006-12-06 |
2012-02-14 |
Albert Einstein College Of Medicine Of Yeshiva University |
Multi-microRNA methods and compositions
|
|
JP2010516249A
(ja)
|
2007-01-17 |
2010-05-20 |
ザ・ジョンズ・ホプキンス・ユニバーシティ |
腫瘍治療のためのミクロrnaに関する組成物及び方法
|
|
WO2009012263A2
(en)
*
|
2007-07-18 |
2009-01-22 |
The Trustees Of Columbia University In The City Of New York |
Tissue-specific micrornas and compositions and uses thereof
|
|
CA2694928A1
(en)
|
2007-07-31 |
2009-02-05 |
Board Of Regents, The University Of Texas System |
Micro-rnas that control myosin expression and myofiber identity
|
|
WO2009075817A1
(en)
|
2007-12-06 |
2009-06-18 |
Minerva Biotechnologies Corporation |
Method for treating cancer using interference rna
|
|
JP2010094122A
(ja)
|
2008-06-12 |
2010-04-30 |
Keio Gijuku |
バイオマーカーとしてのマイクロrnaを用いた頭頸部腫瘍の診断・治療選択
|
|
US8729041B2
(en)
|
2008-12-03 |
2014-05-20 |
The Johns Hopkins University |
Compositions and methods for treating hepatic neoplasia
|
|
MA33488B1
(fr)
|
2009-06-08 |
2012-08-01 |
Miragen Therapeutics |
Motifs de modification chimique pour des inhibiteurs et mimétiques de miarn
|
|
US8796238B2
(en)
|
2009-09-17 |
2014-08-05 |
Sigma-Aldrich Co. Llc |
Short RNA mimetics
|
|
US20120302626A1
(en)
*
|
2009-12-04 |
2012-11-29 |
Sandeep Dave |
Microrna and use thereof in identification of b cell malignancies
|
|
US8768630B2
(en)
*
|
2010-02-19 |
2014-07-01 |
The Regents Of The University Of Michigan |
miRNA target prediction
|
|
CN103154246B
(zh)
|
2010-05-14 |
2015-11-25 |
达那-法伯癌症研究所 |
用于治疗白血病的组合物和方法
|
|
EP3118316A1
(en)
|
2010-09-02 |
2017-01-18 |
Université de Mons |
Agents useful in treating facioscapulohumeral muscular dystrophy
|
|
AU2012212023B9
(en)
|
2011-02-03 |
2017-01-12 |
Mirna Therapeutics, Inc. |
Synthetic mimics of miR-34
|
|
US9222085B2
(en)
|
2011-02-03 |
2015-12-29 |
Mirna Therapeutics, Inc. |
Synthetic mimics of MIR-124
|
|
CA2842798C
(en)
*
|
2011-07-25 |
2021-02-23 |
Nationwide Children's Hospital, Inc. |
Recombinant virus products and methods for inhibition of expression of dux4
|
|
WO2013019623A2
(en)
|
2011-07-29 |
2013-02-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject
|
|
EP2763703B1
(en)
|
2011-10-06 |
2018-02-14 |
Miragen Therapeutics, Inc. |
Control of whole body energy homeostasis by microrna regulation
|
|
TWI516267B
(zh)
|
2011-11-07 |
2016-01-11 |
臺北榮民總醫院 |
抑制癌症或腫瘤細胞之類癌幹細胞特性及抗化學及放射治療特性的醫藥組合物
|
|
WO2013120038A2
(en)
|
2012-02-10 |
2013-08-15 |
Regents Of The University Of Minnesota |
Morpholino targeting dux4 for treating fshd
|
|
WO2013120497A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
DK2872147T3
(da)
*
|
2012-07-13 |
2023-02-20 |
Wave Life Sciences Ltd |
Fremgangsmåde til fremstilling af kirale oligonukleotider
|
|
US11293064B2
(en)
*
|
2013-05-02 |
2022-04-05 |
Thomas Jefferson University |
Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases
|
|
US9518300B2
(en)
|
2014-04-14 |
2016-12-13 |
Dana-Farber Cancer Institute, Inc. |
Composition and method for treating a hematological malignancy
|
|
CN106794260B
(zh)
|
2014-04-25 |
2021-02-23 |
儿童医疗中心有限公司 |
治疗血红蛋白病的组合物和方法
|
|
US10538763B2
(en)
*
|
2015-01-16 |
2020-01-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulation of DUX4
|
|
EP3286318A2
(en)
|
2015-04-22 |
2018-02-28 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
WO2017004243A1
(en)
*
|
2015-06-29 |
2017-01-05 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
|
WO2017007886A2
(en)
|
2015-07-08 |
2017-01-12 |
Idera Pharmaceuticals, Inc. |
Compositions for inhibiting dux4 gene expression and uses thereof
|
|
EP3426781B1
(en)
*
|
2016-03-07 |
2024-06-26 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Micrornas and methods of their use
|
|
BR112018070249A2
(pt)
*
|
2016-04-02 |
2019-01-29 |
Research Institute At Nationwide Children's Hospital |
sistema promotor de u6 modificada para expressão específica de tecido
|
|
EP3684378A4
(en)
*
|
2017-09-19 |
2021-06-16 |
Children's National Medical Center |
GAPMERS AND THEIR USES IN THE TREATMENT OF MUSCLE DYSTROPHY
|
|
MA49923A
(fr)
*
|
2017-10-02 |
2020-06-24 |
Res Inst Nationwide Childrens Hospital |
Système de déciblage de miarn pour interférence spécifique d'un tissu
|
|
US10676744B2
(en)
*
|
2017-10-13 |
2020-06-09 |
University Of South Carolina |
Modulation of adipose tissue macrophage phenotype by use of MicroRNA-30
|
|
US11268305B2
(en)
|
2018-05-17 |
2022-03-08 |
Kiekert Ag |
Latching system for a motor vehicle
|
|
WO2020028134A1
(en)
*
|
2018-07-30 |
2020-02-06 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for treating cancer
|
|
EP3830259A4
(en)
|
2018-08-02 |
2022-05-04 |
Dyne Therapeutics, Inc. |
MUSCLE TARGETED COMPLEXES AND THEIR USES IN THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
|
|
US12331293B2
(en)
*
|
2018-11-02 |
2025-06-17 |
Biomarin Technologies B.V. |
Bispecific antisense oligonucleotides for dystrophin exon skipping
|
|
TW202104595A
(zh)
|
2019-03-29 |
2021-02-01 |
日商田邊三菱製藥股份有限公司 |
用來調節dux4的表現之化合物、方法及醫藥組成物
|
|
JP7627495B2
(ja)
|
2019-07-12 |
2025-02-06 |
学校法人東海大学 |
DUX4 pre-mRNAのスプライシングを変化させるアンチセンスオリゴヌクレオチド
|
|
CN122124274A
(zh)
|
2020-01-10 |
2026-06-02 |
达因疗法公司 |
肌肉靶向复合物及其用于治疗面肩肱型肌营养不良的用途
|
|
TW202144572A
(zh)
|
2020-03-19 |
2021-12-01 |
美商亞維代堤生物科學公司 |
治療臉肩胛肱骨肌肉失養症之組合物及方法
|
|
AU2021257213A1
(en)
|
2020-04-17 |
2022-11-03 |
Nevada Research & Innovation Corporation |
CRISPR-inhibition for facioscapulohumeral muscular dystrophy
|
|
GB202009618D0
(en)
|
2020-06-24 |
2020-08-05 |
Ucl Business Ltd |
Therapeutics for the treatment of FSHD
|
|
CN116348139A
(zh)
|
2020-07-23 |
2023-06-27 |
达因疗法公司 |
肌肉靶向复合物及其用于治疗面肩肱型肌营养不良的用途
|
|
AU2021313058A1
(en)
|
2020-07-23 |
2023-03-30 |
Dyne Therapeutics, Inc. |
Muscle-targeting complexes and uses thereof
|
|
WO2022043566A1
(en)
|
2020-08-31 |
2022-03-03 |
Merck Patent Gmbh |
Method and device for manufacturing of solid oral dosage forms
|
|
EP4204556A4
(en)
|
2020-08-31 |
2024-10-02 |
Modalis Therapeutics Corporation |
Method for treating facioscapulohumeral muscular dystrophy (fshd) by targeting dux4 gene
|
|
AR123420A1
(es)
|
2020-09-01 |
2022-11-30 |
Ultragenyx Pharmaceutical Inc |
Inhibidores de dux4 y métodos de uso de estos
|
|
AU2021342155A1
(en)
|
2020-09-11 |
2023-04-13 |
Arrowhead Pharmaceuticals, Inc. |
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
|
|
WO2022056269A1
(en)
|
2020-09-11 |
2022-03-17 |
Arrowhead Pharmaceuticals, Inc. |
Skeletal muscle delivery platforms and methods of use
|
|
JP2022055361A
(ja)
|
2020-09-28 |
2022-04-07 |
田辺三菱製薬株式会社 |
Dux4の発現を調節するための医薬組成物
|